Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1997 Dec;88(12):1190–1198. doi: 10.1111/j.1349-7006.1997.tb00348.x

Nitric Oxide Synthase Activity in Human Lung Cancer

Hisao Fujimoto 1, Yukio Ando 1,, Taro Yamashita 1, Hisayasu Terazaki 1, Yoshiya Tanaka 1, Jiichiro Sasaki 1, Mitsuhiro Matsumoto 1, Moritaka Suga 1, Masayuki Ando 1
PMCID: PMC5921342  PMID: 9473737

Abstract

Nitric oxide synthases (NOS) exist in human tumor cell lines and solid tumor tissues, and it has been suggested that NO may play important roles in growth, progression or metastasis of tumors. We investigated the activity and distribution of NOS in a series of human lung cancer and normal lung tissues. Seventy‐two primary lung cancer samples (44 cases of adenocarcinoma, 18 of squamous cell carcinoma, 4 of large cell carcinoma, 2 of small cell carcinoma, 2 of adenosquamous carcinoma, and 2 of carcinoids) and corresponding normal lung samples were obtained from surgically treated patients. In normal lung tissues, little NOS activity was observed with no correlation between the patients' age and NOS activity. The total NOS activities in lung adenocarcinoma samples were significantly higher than those in other types of lung cancers or normal lung samples (P<0.05), Analysis by tumor grade of the adenocarcinoma samples revealed no significant difference of NOS activity between grades. TNM classification showed that, although T stage did not correlate with NOS activity, cancer tissues from patients with N2 disease tended to have lower activity than those from patients with NO or Nl disease. Immunohistochemical studies revealed that the intensity of NOS immunoreactivity correlated with NOS activity. These results suggest that NO may play an important role in the metabolism and behavior of lung cancers, especially adenocarcinoma.

Keywords: Nitric oxide, Nitric oxide synthase, Human, Lung cancer

Full Text

The Full Text of this article is available as a PDF (1,007.9 KB).

REFERENCES

  • 1. ) Palmer , R. M. J. , Ferrige , A. G. and Moncada , S.Nitric oxide release accounts for the biological activity of en‐dothelium‐derived relaxing factor . Nature , 327 , 524 – 526 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Moncada , S. , Palmer , R. M. J. and Higgs , E. J.Nitric oxide: physiology, pathophysiology, and pharmacology . Pharmacol. Rev. , 43 , 109 – 142 ( 1991. ). [PubMed] [Google Scholar]
  • 3. ) Moncada , S. and Higgs , A.The L‐arginine‐nitric oxide pathway . N. Engl. J. Med. 329 , 2002 – 2112 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Knowles , R. G. and Moncada , S.Nitric oxide synthases in mammals . Biochem. J. , 298 , 249 – 258 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Sakuma , I. , Stuehr , D. J. , Gross , S. S. , Nathan , C. and Levi , R.Identification of arginine as a precursorof endothelium‐derived relaxing factor . Proc. Natl. Acad. Sci. USA , 85 , 8664 – 8667 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Nava , E. , Palmer , R. M. and Moncada , S.Inhibition of nitric oxide synthesis in septic shock: how much is beneficial ? Lancet , 338 , 1555 – 1557 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Forstermann , U. , Gorsky , L. D. , Pollock , J. S. , Ishii , K. , Schmidt , H. H. H. W. , Heller , M. and Murad , F.Hormone‐induced biosynthesis ofendothelium‐derived relaxing factor/nitric oxide‐like material in N1E‐115 neuroblastoma cells requires calcium and calmodulin . Mol. Pharmacol , 38 , 7 – 13 ( 1990. ). [PubMed] [Google Scholar]
  • 8. ) Werner‐Felmayer , G. , Werner , E. R. , Fuchs , D. , Hausen , A. , Mayer , B. , Reibnegger , G. , Weiss , G. and Wachter , H.Ca2+/calmodulin‐dependent nitric oxide synthase activity in the human cervix cell line ME‐180 . Biochem. J. , 289 , 357 – 361 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Jenkins , D. C. , Charles , I. G. , Baylis , I. A. , Lelchuk , R. , Radomski , M. W. and Moncada , S.Human colon cancer cell lines show a diverse pattern of nitric oxide synthase. gene expression and nitric oxide generation . Br, J. Cancer , 70 , 847 – 849 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Amber , I. J. , Hibbs , J. B. , Jr. , Taintor , R. R. and Vavrin , Z.The L‐arginine dependent effector mechanism is induced in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages . J. Leukocyte Biol , 43 , 187 – 192 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Radomski , M. W. , Jenkins , D. C. , Holmes , L. and Moncada , S.Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets . Cancer Res. , 51 , 6073 – 6078 ( 1991. ). [PubMed] [Google Scholar]
  • 12. ) Sherman , P. A. , Laubach , V. E. , Reep , B. R. and Wood , E. R.Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line . Biochemistry , 32 , 11600 – 11605 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Thomsen , L. L. , Lawton , F. G. , Knowles , R. G. , Beealey , J. E. , Riveros , M. V. and Moncada , S.Nitric oxide synthase activity in human gynecological cancer . Cancer Res. , 54 , 1352 – 1354 ( 1994. ). [PubMed] [Google Scholar]
  • 14. ) Cobbs , C. S. , Brenman , J. E. , Aldape , D. , Bredt , S. B. and Israel , A.Expression of nitric oxide synthase in human central nervous system tumors . Cancer Res. , 55 , 727 – 730 ( 1995. ). [PubMed] [Google Scholar]
  • 15. ) Thomsen , L. L. , Miles , D. W. , Happerfleld , L. , Bobrow , L. G. , Knowles , R. G. and Moncada , S.Nitric oxide synthase activity in human breast cancer . Br. J. Cancer , 72 , 41 – 44 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. ) Xie , K. and Fidler , I. J.Induction of apoptosis in transformed fibroblasts can be mediated via endogenous and exogenous nitric oxide . Proc. Am. Assoc. Cancer Res. , 34 , 95 ( 1993. ). [Google Scholar]
  • 17. ) Andrade , S. , Hart , I. and Piper , P.Inhibitors of nitric oxide synthase selectively reduce flow in tumor‐associated neovasculature . Br. J. Pharmacol. 107 , 1092 – 1095 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Maeda , H. , Noguchi , Y. , Sato , K. and Akaike , T.Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor . Jpn. J. Cancer Res. , 85 , 331 – 334 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. ) Kubes , P. and Granger , D.Nitric oxide modulates micro‐vascularpermeability . Am. J. Physiol , 262 , 611 – 615 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Jenkins , D. C. , Charles , I. G. , Thomsen , L. L. , Moss , D. W. , Holmes , L. S. , Baylis , S. A. , Rhodes , P. , Westmore , K. , Emson , P. C. and Moncada , S.Roles of nitric oxide in tumor growth . Proc. Natl. Acad. Sci. USA , 92 , 4392 – 4396 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. ) World Health Organization. The World Health Organizationhistological typing of lung cancer . Am.J. Clin. Pathol , 77 , 123 – 136 ( 1982. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Isobe , Y. , Chen , S. T. , Nakane , P. K. and Brown , W. R.Studies on translocation of immunoglobulins across intestinal epithelium I. Improvements in the peroxidase‐labeled antibody method for application to study of human intestinal mucosa . Acta Histochem, Cytochem. , 10 , 161 – 171 ( 1977. ). [Google Scholar]
  • 23. ) Bredt , D. S. and Snyder , S. H.Nitric oxide mediates glutamate‐linked enhancement of cGMP levels in the cerebellum . Proc. Natl. Acad. Sci. USA , 86 , 9030 – 9033 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Asano , K. , Chee , C. B. E. , Gaston , B. , Lilly , C. M. , Gerard , C. , Drazen , J. M. and Stamler , J. S.Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelialcells . Proc. Natl. Acad. Sci USA , 91 , 10089 – 10093 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. ) Shaul , P. W. , North , A. J. , Wu , L C. , Wells , L. B. , Brannon , T. S. , Lau , K. S. , Michel , T. , Margraf , L. R. and Star , R. A.Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium . J. Clin. Invest. , 94 , 2231 – 2236 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Fidler , I. J.Critical factors in the biology of human cancer metastasis . Cancer Res. , 50 , 6130 – 6138 ( 1990. ). [PubMed] [Google Scholar]
  • 27. ) Nicolson , G.Cancer metastasis: tumor cells and host‐organ properties important in metastasis to specific secondary sites . Biochim. Biophys. Acta , 948 , 175 – 224 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Radinsky , R.Growth factors and their receptors in metastasis . Semin. Cancer Biol , 2 , 169 – 177 ( 1991. ). [PubMed] [Google Scholar]
  • 29. ) Dong , Z. , Staroselsky , A. H. , Qi , X. , Xie , K. and Fidler , I. J.Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K‐1735 murine melanoma cells . Cancer Res. , 54 , 789 – 793 ( 1994. ). [PubMed] [Google Scholar]
  • 30. ) Palmer , R. M.J. , Rees , D.D. , Ashton , D. S. and Moncada , S.Vascular endothelial cells synthesize nitric oxide from L‐arginine . Nature , 333 , 664 – 666 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Ignarro , L. J. , Buga , G. M. , Wood , K. S. , Byrns , R. E. and Chaudhuri , G.Endothelium‐derived relaxing factor produced and released from artery and vein is nitric oxide . Proc. Natl. Acad. Sci. USA , 87 , 5193 – 5197 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. ) Weidner , N. , Folkman , J. , Pozza , F. , Pierantonio , B. , Allred , E. N. , Moore , D. H. , Meli , S. and Gasparini , G.Tumor angiogenesis: a new significant and independent prognostic indicator in early‐stage breast carcinoma . J. Natl. Cancer Inst. , 84 , 1875 – 1887 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Radomski , M. W. , Palmar , R. M. J. and Moncada , S.An L‐arginine/nitric oxide pathway present in human platelets regulates aggregation . Proc.Natl. Acad.Sci. USA , 87 , 5193 – 5197 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. ) Radomski , M. W. , Palmar , R. M. J. and Moncada , S.Characterization of the L‐arginine :nitric oxide pathway in human platelets . Br. J. Pharmacol. , 101 , 325 – 328 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. ) Sugimoto , Y. , Oh‐hara , T. , Watanabe , M. , Uamori , T. and Tsuruo , T. . Cancer Res. , 47 , 3115 – 3117 ( 1987. ). [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES